3.5

CiteScore

2.3

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Brianna Lide, Shane McGuire, Hong Liu, Cristina Chandler. Mast cell activation syndrome—anesthetic challenges in two different clinical scenarios[J]. The Journal of Biomedical Research, 2022, 36(6): 435-439. DOI: 10.7555/JBR.36.20220071
Citation: Brianna Lide, Shane McGuire, Hong Liu, Cristina Chandler. Mast cell activation syndrome—anesthetic challenges in two different clinical scenarios[J]. The Journal of Biomedical Research, 2022, 36(6): 435-439. DOI: 10.7555/JBR.36.20220071

Mast cell activation syndrome—anesthetic challenges in two different clinical scenarios

  • Mast cell activation syndrome (MCAS) includes a group of disorders that result in the inappropriate release of inflammatory mediators from mast cells. These mediators can affect multiple organ systems and lead to significant morbidity, and possible fatality. Although reactions, typically in response to various nonspecific stimuli, are usually mild, they may put those with MCAS at increased risk of anaphylaxis. In this case report, we present two clinical scenarios of MCAS, and identify possible factors triggering mast cell mediator release. We also define a preoperative preventive pathway, outline anesthetic considerations, and discuss the management of immediate hypersensitivity reactions in patients with MCAS. Meticulous preoperative preparation, avoidance of triggers, and development of a plan to treat possible adverse organ responses are paramount of good outcomes.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return